These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6241082)

  • 1. [A study of the antitumor action of glyciphosphoramide].
    He S; Ji XJ; Zhu TX; Wang NG; Su XL; Cao FZ; Pan ZK; Li ZR; Bao TT; Han R
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1984 Oct; 6(5):334-7. PubMed ID: 6241082
    [No Abstract]   [Full Text] [Related]  

  • 2. [Strategies for studies on mechanism of action of antineoplastic agents].
    Kuśnierczyk H
    Postepy Hig Med Dosw; 1995; 49(1):85-96. PubMed ID: 8657622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cytostatic effects of bifolar and chlofiden. Effect on protein synthesis and cell cycle].
    Sharykina NI; Bukhtiarova TA; Kudriavtseva IG; Pavlovskaia GP
    Ukr Biokhim Zh (1999); 2004; 76(1):123-9. PubMed ID: 15909427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antitumor properties of 2-phenazinylthioureidotyrosine].
    Sidorik OA; Terent'ev AG; Shevchenko IM
    Mikrobiol Zh; 1975; 37(4):500-1. PubMed ID: 1214673
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytotoxic activity relative to 4-hydroxycyclophosphamide and phosphoramide mustard concentrations in the plasma of cyclophosphamide-treated rats.
    Powers JF; Sladek NE
    Cancer Res; 1983 Mar; 43(3):1101-6. PubMed ID: 6825082
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative study of the anti-inflammatory, analgesic and antipyretic actions of antitumor preparations].
    Trinus FP; Chernov VA; Riabukha TK; Sharykina NI
    Vopr Onkol; 1980; 26(5):49-54. PubMed ID: 6966858
    [No Abstract]   [Full Text] [Related]  

  • 7. [Diazo derivatives of amino acids and peptides as possible antineoplastic chemotherapeutic agents. XII. Experimental antineoplastic activity of hydrazone derivatives of N-diazoacetylglycine hydrazide].
    Brambilla G; Baldini L; Cavanna M
    Boll Soc Ital Biol Sper; 1966 Nov; 42(22):1675-8. PubMed ID: 5982442
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of the mutagenicity and teratogenicity of cyclophosphamide and its active metabolites, 4-hydroxycyclophosphamide, phosphoramide mustard, and acrolein.
    Hales BF
    Cancer Res; 1982 Aug; 42(8):3016-21. PubMed ID: 7046914
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical phase II trial of a new antineoplastic drug, glyciphosphoramide (GPM)].
    Sun Y
    Zhonghua Zhong Liu Za Zhi; 1984 Sep; 6(5):375-8. PubMed ID: 6534723
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical phase II trial of a new antineoplastic drug--glyciphosphoramide].
    Sun Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1984 Aug; 6(4):273-6. PubMed ID: 6241067
    [No Abstract]   [Full Text] [Related]  

  • 11. [Diazo derivatives of amino acids and peptides as possible antineoplastic chemotherapeutic agents. XI. Experimental antineoplastic activity of N-diazoacetyl-D,L-phenylalanine ethyl ester and of N-diazoacetyl-D,L-phenylalanine hydrazide].
    Baldini L; Brambilla G; Cavanna M
    Boll Soc Ital Biol Sper; 1966 Nov; 42(22):1672-5. PubMed ID: 5982441
    [No Abstract]   [Full Text] [Related]  

  • 12. [Diazo derivatives of amino acids and peptides as possible antineoplastic chemotherapeutic agents. X. Experimental antineoplastic activity of N-diazoacetyl-D,L-alanine ethyl ester and of N-diazoacetyl-D,L-alanine hydrazide].
    Baldini L; Brambilla G
    Boll Soc Ital Biol Sper; 1966 Nov; 42(22):1669-72. PubMed ID: 5982440
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical phase I trial of a new anti-neoplastic drug--glyciphosphoramide].
    Sun Y
    Zhonghua Zhong Liu Za Zhi; 1984 Jul; 6(4):293-5. PubMed ID: 6525950
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of desacetyl vinblastine amide (DVA) against human sarcomas heterotransplanted in nude mice.
    Sordillo PP; Hajdu SI; Magill GB; Lesser M; Helson L
    Cancer Clin Trials; 1980; 3(4):391-4. PubMed ID: 7428143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical evaluation of glyciphosphoramide used alone and in combination with other drugs].
    Wang ZY
    Zhonghua Zhong Liu Za Zhi; 1984 Sep; 6(5):379-81. PubMed ID: 6398774
    [No Abstract]   [Full Text] [Related]  

  • 16. [Determination of glyciphosphoramide and its metabolite in plasma and the pharmacokinetics in rats after oral administration].
    Wang WJ; Bai JY; Zhu XY
    Yao Xue Xue Bao; 1993; 28(10):738-43. PubMed ID: 8009985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased antitumour activity of mesyl-I-aldophosphamide-perhydrothiazine, in vivo but not in vitro, compared to I-aldophosphamide-perhydrothiazine.
    Voelcker G; Pfeiffer B; Schnee A; Hohorst H
    J Cancer Res Clin Oncol; 2000 Feb; 126(2):74-8. PubMed ID: 10664245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor properties of selected 1,2,4-triazine derivatives.
    Mordarski M; Wieczorek J; Fiszer L; Nantka-Namirski P; Rykowski A
    Arch Immunol Ther Exp (Warsz); 1980; 28(5):717-25. PubMed ID: 7212979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of the preclinical antitumor activity and toxicology of L-asparaginase derived from E. coli.
    Charles LM; Bono VH
    Cancer Treat Rep; 1981; 65 Suppl 4():39-46. PubMed ID: 7049380
    [No Abstract]   [Full Text] [Related]  

  • 20. Sulfonyl-containing aldophosphamide analogues as novel anticancer prodrugs targeted against cyclophosphamide-resistant tumor cell lines.
    Jain M; Fan J; Baturay NZ; Kwon CH
    J Med Chem; 2004 Jul; 47(15):3843-52. PubMed ID: 15239662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.